Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Towards strategies to optimize outcomes in CLL

Florence Cymbalista • 7 Oct 2022
ERIC 2022
Chronic Lymphocytic Leukemia Leukemia

Florence Cymbalista, MD, Hôpital Avicenne, Bobigny, France, shares her perspectives on improving the outcomes of patients with chronic lymphocytic leukemia (CLL), discussing the importance of better managing patients outside of the hospital, integrating advances in our understanding of the biology of the disease in clinical practice, and well-planned clinical trials. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Florence Cymbalista

2:07
Moving towards time-limited treatment in frontline CLL
Florence Cymbalista • 7 Oct 2022
2:27
The importance of TP53 & IGHV testing before treatment initiation in CLL
Florence Cymbalista • 7 Oct 2022
1:33
Challenges in interpreting the results of genomic tests in CLL
Florence Cymbalista • 7 Oct 2022
1:21
Identifying low-burden TP53 mutations with NGS in CLL
Florence Cymbalista • 7 Oct 2022

Related Videos

6:38
Key papers in cardio-oncology from 2023 of relevance to hematologists
Alexander Lyon • 25 Apr 2024
7:50
The ESC guidelines on cardio-oncology: incorporating the guidelines into clinical practice
Alexander Lyon • 25 Apr 2024
1:56
Approaching treatment selection and sequencing with the recent influx of BTK inhibitors in CLL
Dima El-Sharkawi • 28 Apr 2024
1:17
Using an AI model to quantify under-utilization of alloSCT for AML in the UK
Thomas Coats • 29 Apr 2024
The content of VJHemOnc is intended for healthcare professionals